HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cancer anorexia and cachexia.

Abstract
Patients with cancer cachexia experience a profound wasting of adipose tissue and lean body mass. Anorexia, although often present, is insufficient to account for tissue wasting because 1) cachexia involves massive depletion of skeletal muscle that does not occur during anorexia, 2) nutritional supplementation cannot replenish the loss of lean body mass, 3) cachexia can occur without anorexia, and 4) food intake might be normal for the lower weight of the cancer patient. Anorexia can arise from 1) decreased taste and smell of food, 2) early satiety, 3) dysfunctional hypothalamic membrane adenylate cyclase, 4) increased brain tryptophan, and 5) cytokine production. Appetite stimulants such as cyproheptadine, medroxyprogesterone acetate, and megestrol acetate do not significantly improve lean body mass. Tumor products might be more important in the development of cachexia. Cachectic patients excrete in their urine a lipid-mobilizing factor that directly stimulates lipolysis in a cyclic AMP-dependent manner and increases energy expenditure. Loss of skeletal muscle in cachexia is caused by upregulation of the ubiquitin-proteasome catabolic pathway. Cachexia-inducing tumors elaborate a sulfated glycoprotein, which directly initiates protein catabolism in skeletal muscle. The action of this proteolysis-inducing factor is attenuated by the polyunsaturated fatty acid eicosapentaenoic acid, which is also effective in preventing loss of skeletal muscle in cancer patients. Antagonists of tumor catabolic factors will provide important new agents in the treatment of cancer cachexia.
AuthorsM J Tisdale
JournalNutrition (Burbank, Los Angeles County, Calif.) (Nutrition) Vol. 17 Issue 5 Pg. 438-42 (May 2001) ISSN: 0899-9007 [Print] United States
PMID11377146 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Appetite Stimulants
  • Blood Proteins
  • Eicosanoic Acids
  • Peptides
  • Proteins
  • Proteoglycans
  • lipid mobilizing substance
  • proteolysis-inducing peptide
Topics
  • Anorexia (etiology, metabolism, therapy)
  • Appetite Stimulants (therapeutic use)
  • Blood Proteins (metabolism)
  • Cachexia (etiology, metabolism, therapy)
  • Eicosanoic Acids (therapeutic use)
  • Humans
  • Lipid Metabolism
  • Muscle, Skeletal (metabolism)
  • Neoplasms (metabolism, physiopathology)
  • Peptides (metabolism)
  • Proteins (metabolism)
  • Proteoglycans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: